Amanote Research

Amanote Research

    RegisterSign In

Indications of Rituximab in Autoimmune Diseases

Drug Discovery Today: Therapeutic Strategies
doi 10.1016/j.ddstr.2009.10.001
Full Text
Open PDF
Abstract

Available in full text

Date

March 1, 2009

Authors
Iñaki Sanz
Publisher

Elsevier BV


Related search

Psy170 - Impact of Multiple Indications on Price and Access of Drugs for Autoimmune Diseases

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Editorial – NETs in Autoimmune Diseases

Autoimmunity
AllergyImmunology
2018English

Kidney Damage in Autoimmune Diseases

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2010English

Dyslipidaemia in Rheumatological Autoimmune Diseases

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2011English

Coinhibitory Molecules in Autoimmune Diseases

Clinical and Developmental Immunology
2012English

Anticytokine Therapy in Autoimmune Diseases.

Internal Medicine
Internal MedicineMedicine
1999English

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

Turkish Journal of Haematology
Hematology
2012English

Fetal Outcomes After Rituximab Exposure in Women With Autoimmune Vasculitis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Neurologic Manifestations of Autoimmune Diseases

Autoimmune Diseases
AllergyImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy